您当前的位置: 首页 > 数据库
  • 全部(2447)
  • 腹部手术(342)
  • 胸科手术(70)
  • 血管手术(5)
  • 心脏手术(97)
  • 神经外科(4)
  • 头颈部(35)
  • 骨科(78)
  • 泌尿外科(0)
  • 妇产手术(77)
  • 日间手术(26)
  • 手术室外(28)
  • 创伤和烧伤(0)
  • 非心脏手术(472)
  • 老年(0)
  • 小儿新生儿(189)
  • 特殊患者(42)
  • 未说明手术类型(982)
  • 术前宣教(21)
  • 术前评估(33)
  • 术前用药(15)
  • 术前禁食水(12)
  • 麻醉选择(21)
  • 麻醉用药(10)
  • 术中监测(23)
  • 液体管理(14)
  • 血液保护(3)
  • 体温管理(8)
  • 术后疼痛(62)
  • POD(8)
  • PONV(10)
  • 术后康复(50)
  • 特殊情况(43)
  • 术前肠道准备(9)
Array ( [id] => 1670 [catid] => 193 [title] => Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1670.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://journals.lww.com/ejanaesthesiology/pages/articleviewer.aspx?year=9900&issue=00000&article=00274&type=Fulltext [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => The European Journal of Anaesthesiology [pdf] => [tjyjyw] => [lyyw] => Patients taking SGLT2i medications should consume clear fluids approximately 2 h before the procedure to keep regular hydration. (Evidence level:very Low;Recommendation grade:weak) [laiyuan] => 服用SGLT2i类药物的患者应在术前2 h左右饮用清澈的液体,以保持规律的水化。(证据分级:极低;推荐强度:弱推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
服用SGLT2i类药物的患者应在术前2 h左右饮用清澈的液体,以保持规律的水化。(证据分级:极低;推荐强度:弱推荐)

Patients taking SGLT2i medications should consume clear fluids approximately 2 h before the procedure to keep regular hydration. (Evidence level:very Low;Recommendation grade:weak)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:The European Journal of Anaesthesiology

阅读
Array ( [id] => 1671 [catid] => 191 [title] => Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1671.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://journals.lww.com/ejanaesthesiology/pages/articleviewer.aspx?year=9900&issue=00000&article=00275&type=Fulltext [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => The European Journal of Anaesthesiology [pdf] => [tjyjyw] => [lyyw] => Euglycemic diabetic ketoacidosis should be suspected in this category of patients, and blood β-hydroxybutyrate is a functional confirmatory test. (Evidence level:very Low;Recommendation grade:weak) [laiyuan] => 对于该类患者应怀疑正常血糖糖尿病酮症酸中毒,血β -羟丁酸是一种功能性的验证试验。(证据分级:极低;推荐强度:不推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
对于该类患者应怀疑正常血糖糖尿病酮症酸中毒,血β -羟丁酸是一种功能性的验证试验。(证据分级:极低;推荐强度:不推荐)

Euglycemic diabetic ketoacidosis should be suspected in this category of patients, and blood β-hydroxybutyrate is a functional confirmatory test. (Evidence level:very Low;Recommendation grade:weak)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:The European Journal of Anaesthesiology

阅读
Array ( [id] => 1672 [catid] => 191 [title] => Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1672.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://journals.lww.com/ejanaesthesiology/pages/articleviewer.aspx?year=9900&issue=00000&article=00276&type=Fulltext [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => The European Journal of Anaesthesiology [pdf] => [tjyjyw] => [lyyw] => If a patient taking SGLT2i drugs did not discontinue the medication in time, dehydration caused by bowel preparation for endoscopy can increase the ketone levels, and the patient should be adequately hydrated before leaving the hospital. (Evidence level:very Low;Recommendation grade:weak) [laiyuan] => 服用SGLT2i类药物的患者如未及时停药,肠道准备引起的脱水可使酮体水平升高,患者出院前应充分水化。(证据分级:极低;推荐强度:弱推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
服用SGLT2i类药物的患者如未及时停药,肠道准备引起的脱水可使酮体水平升高,患者出院前应充分水化。(证据分级:极低;推荐强度:弱推荐)

If a patient taking SGLT2i drugs did not discontinue the medication in time, dehydration caused by bowel preparation for endoscopy can increase the ketone levels, and the patient should be adequately hydrated before leaving the hospital. (Evidence level:very Low;Recommendation grade:weak)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:The European Journal of Anaesthesiology

阅读
Array ( [id] => 1673 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1673.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => We recommend implementing local protocols of venous thromboprophylaxis to reduce the risk of perioperative complications. These protocols include early ambulation as well as pharmacological and mechanical prophylaxis, whose indication, methods, and duration depend on the risk for VTE of the patient and surgery, the bleeding risk, and the perioperative care pathway.(Evidence level:High;Recommendation grade:Strong) [laiyuan] => 我们建议实施静脉血栓预防的局部方案,以减少围手术期并发症的风险。这些方案包括早期走动以及药物和机械预防,其适应症、方法和持续时间取决于患者和手术静脉血栓栓塞风险,出血风险和围手术期护理途径。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
我们建议实施静脉血栓预防的局部方案,以减少围手术期并发症的风险。这些方案包括早期走动以及药物和机械预防,其适应症、方法和持续时间取决于患者和手术静脉血栓栓塞风险,出血风险和围手术期护理途径。(证据分级:高;推荐强度:强推荐)

We recommend implementing local protocols of venous thromboprophylaxis to reduce the risk of perioperative complications. These protocols include early ambulation as well as pharmacological and mechanical prophylaxis, whose indication, methods, and duration depend on the risk for VTE of the patient and surgery, the bleeding risk, and the perioperative care pathway.(Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1674 [catid] => 303 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1674.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => After surgery with a low risk for VTE, if the patient has a major personal risk factor for VTE or several minor risk factors, we suggest using thromboprophylaxis with an anticoagulant for a minimum of 7 days. (Evidence level:moderate/Low;Recommendation grade:Strong) [laiyuan] => 在静脉血栓栓塞风险低的手术后,如果患者有发生静脉血栓栓塞主要个人危险因素或几个次要危险因素,我们建议使用抗凝药物至少7天。(证据分级:中或低;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
在静脉血栓栓塞风险低的手术后,如果患者有发生静脉血栓栓塞主要个人危险因素或几个次要危险因素,我们建议使用抗凝药物至少7天。(证据分级:中或低;推荐强度:强推荐)

After surgery with a low risk for VTE, if the patient has a major personal risk factor for VTE or several minor risk factors, we suggest using thromboprophylaxis with an anticoagulant for a minimum of 7 days. (Evidence level:moderate/Low;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1675 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1675.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => We recommend using pharmacological thromboprophylaxis after THA or TKA.(Evidence level:High;Recommendation grade:Strong) [laiyuan] => 我们建议在全髋关节置换术或全膝关节置换术后采用药物性血栓预防措施。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在全髋关节置换术或全膝关节置换术后采用药物性血栓预防措施。(证据分级:高;推荐强度:强推荐)

We recommend using pharmacological thromboprophylaxis after THA or TKA.(Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1676 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1676.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => We recommend pharmacological thromboprophylaxis for 35 days after THA and 14 days after TKA.(Evidence level:High;Recommendation grade:Strong) [laiyuan] => 我们建议在全髋关节置换术后进行35天的药物性血栓预防,在全膝关节置换术后进行14天的药物性血栓预防。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在全髋关节置换术后进行35天的药物性血栓预防,在全膝关节置换术后进行14天的药物性血栓预防。(证据分级:高;推荐强度:强推荐)

We recommend pharmacological thromboprophylaxis for 35 days after THA and 14 days after TKA.(Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1677 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1677.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => Either an anticoagulant (Direct Oral Anticoagulant (DOAC), Low Molecular Weight Heparin (LMWH), or fondaparinux) for the entire duration of thromboprophylaxis .(Evidence level:High;Recommendation grade:Strong) [laiyuan] => 在整个血栓预防期间使用一种抗凝剂(直接口服抗凝剂、低分子量肝素或磺达肝癸钠)。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
在整个血栓预防期间使用一种抗凝剂(直接口服抗凝剂、低分子量肝素或磺达肝癸钠)。(证据分级:高;推荐强度:强推荐)

Either an anticoagulant (Direct Oral Anticoagulant (DOAC), Low Molecular Weight Heparin (LMWH), or fondaparinux) for the entire duration of thromboprophylaxis .(Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1678 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2025 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1678.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => Sequential thromboprophylaxis, starting with 5 days of anticoagulant followed by aspirin for 30 days after THA or 9 days after TKA, if the patient is successfully managed in an Enhanced Recovery After Surgery (ERAS) pathway and does not have any major risk factors for VTE** or multiple minor risk factors. (Evidence level:High;Recommendation grade:Strong) [laiyuan] => 进行序贯性血栓预防,在全髋关节置换术后先使用抗凝剂5天,然后使用阿司匹林30天,或者在全膝关节置换术后先使用抗凝剂5天,然后使用阿司匹林9天。前提是患者在术后加速康复路径中得到成功管理,并且没有静脉血栓栓塞的任何主要危险因素或多种次要危险因素。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
进行序贯性血栓预防,在全髋关节置换术后先使用抗凝剂5天,然后使用阿司匹林30天,或者在全膝关节置换术后先使用抗凝剂5天,然后使用阿司匹林9天。前提是患者在术后加速康复路径中得到成功管理,并且没有静脉血栓栓塞的任何主要危险因素或多种次要危险因素。(证据分级:高;推荐强度:强推荐)

Sequential thromboprophylaxis, starting with 5 days of anticoagulant followed by aspirin for 30 days after THA or 9 days after TKA, if the patient is successfully managed in an Enhanced Recovery After Surgery (ERAS) pathway and does not have any major risk factors for VTE** or multiple minor risk factors. (Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读
Array ( [id] => 1679 [catid] => 302 [title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/1679.html [link_id] => 0 [tableid] => 0 [inputip] => 39.144.210.1 [inputtime] => 2024-12-12 11:19:00 [updatetime] => 2024-12-12 11:19:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2024 [guojia] => Anaesthesia, critical care & pain medicine [pdf] => [tjyjyw] => [lyyw] => We recommend the use of LMWH or fondaparinux for 4 weeks after hip fracture surgery.(Evidence level:High;Recommendation grade:Strong) [laiyuan] => 我们建议在髋部骨折手术后使用低分子量肝素或磺达肝癸钠,持续4周。(证据分级:高;推荐强度:强推荐) [znzldj] => B级 [_inputtime] => 1733973540 [_updatetime] => 1733973540 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在髋部骨折手术后使用低分子量肝素或磺达肝癸钠,持续4周。(证据分级:高;推荐强度:强推荐)

We recommend the use of LMWH or fondaparinux for 4 weeks after hip fracture surgery.(Evidence level:High;Recommendation grade:Strong)

证据评价方法:GRADE

指南质量等级:B级

年份:2024

国家:Anaesthesia, critical care & pain medicine

阅读